Evonik's adjusted EBITDA rose 25% in 2024, with profitability improvements and restructuring initiatives positioning the company for continued success.
The company's strong financial performance was driven by factors including favorable price-mix contributions and Axalta's ongoing 2024 Transformation Initiative.